Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | LSS | P48449 | 2/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.38 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4543796 | 0.90 | LIPG (0.43) | LIPGCNR2MAPK14MAPTCYP3A4 | |
| SCHEMBL4540261 | 0.89 | LIPG (0.45) | LIPGCNR2MAPK14MAPTCYP3A4 | |
| SCHEMBL4540508 | 0.88 | CNR2 (0.44) | LIPGCNR2MAPK14CYP3A4EPHX2 | |
| SCHEMBL4543780 | 0.88 | CNR2 (0.47) | LIPGCNR2MAPK14MAPTCYP3A4 | |
| SCHEMBL4538964 | 0.87 | LIPG (0.43) | LIPGCNR2MAPK14CYP3A4EPHX2 | |
| SCHEMBL4542152 | 0.86 | CNR2 (0.44) | LIPGCNR2MAPK14MAPTCYP3A4 | |
| SCHEMBL13707575 | 0.86 | LIPG (0.42) | LIPGCNR2MAPK14CYP3A4EPHX2 | |
| SCHEMBL4542552 | 0.86 | PTGER4 (0.49) | LIPGCNR2MAPK14CYP3A4EPHX2 | |
| SCHEMBL4536942 | 0.85 | LIPG (0.43) | LIPGCNR2MAPK14MAPTCYP3A4 | |
| SCHEMBL4542684 | 0.85 | LIPG (0.43) | LIPGCNR2MAPK14CYP3A4EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009117421-A2 | HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE | KALYPSYS, INC. (US) | 2009-09-24 | — | — | WO | disclosed |
| WO-2009117421-A2 | HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE | KALYPSYS, INC. (US) | 2009-09-24 | — | — | WO | disclosed |